| 000 | 01075 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516083059.0 | ||
| 264 | 0 | _c20120504 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1097-4172 | ||
| 024 | 7 |
_a10.1016/j.cell.2012.02.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevitz, Stuart M | |
| 245 | 0 | 0 |
_aBeyond empiricism: informing vaccine development through innate immunity research. _h[electronic resource] |
| 260 |
_bCell _cMar 2012 |
||
| 300 |
_a1284-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCommunicable Disease Control |
| 650 | 0 | 4 |
_aCommunicable Diseases _ximmunology |
| 650 | 0 | 4 | _aEmpiricism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 |
_aVaccines _ximmunology |
| 700 | 1 | _aGolenbock, Douglas T | |
| 773 | 0 |
_tCell _gvol. 148 _gno. 6 _gp. 1284-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cell.2012.02.012 _zAvailable from publisher's website |
| 999 |
_c21628798 _d21628798 |
||